AAS
OGEN icon

Ameritas Advisory Services’s Oragenics OGEN Stock Holding History

Ameritas Advisory Services’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.12K Buy
+2,000
New +$1.58K ﹤0.01% 1022

Other funds holding OGEN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SJIM
St. Johns Investment Management Jacksonville, Florida $238M AUM 22.04% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Ameritas Advisory Services's OGEN Position: Q1 2026 in Review

Ameritas Advisory Services opened a new position in Oragenics (OGEN) in Q1 2026: 2,000 shares worth $1.12K. The stake represents ﹤0.01% of the portfolio and ranks #1022 among its holdings.

19 funds tracked by Wall St. Rank hold OGEN as of Q1 2026.

  • Ameritas Advisory Services held 2,000 shares of Oragenics worth $1.12K as of Q1 2026.
  • Oragenics was a new Ameritas Advisory Services position in Q1 2026.
  • Oragenics made up ﹤0.01% of Ameritas Advisory Services's portfolio in Q1 2026, its #1022 holding.
  • 19 funds tracked by Wall St. Rank held Oragenics as of Q1 2026.

Based on Ameritas Advisory Services's 13F filing for Q1 2026, filed 12 May 2026.